Author
Indonesia International Institute for Life SciencesORCID 0000-0001-7140-3024Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Amin Addetia, Keiya Uriu, Cameron Stewart…·David Veesler
This study determines the structure of the 2026 Bundibugyo virus glycoprotein and identifies conserved epitopes for antibody therapeutics and pan-ebolavirus vaccines.
Shuhei Tsujino, Sayaka Deguchi, Tomo Nomai…·Kei Sato
The paper investigates the virological features of the SARS-CoV-2 EG.5.1 variant, finding its fitness and antiviral sensitivity comparable to XBB.1.5, with structural differences in spike proteins.
Tomokazu Tamura, Takashi Irie, Sayaka Deguchi…·Takasuke Fukuhara
The paper analyzes the virological characteristics of the SARS-CoV-2 XBB.1.5 variant, showing reduced pathogenicity and impaired MHC expression due to mutations in ORF8 and S.
Tomokazu Tamura, Keita Mizuma, Hesham Nasser…·Kei Sato
This study investigates the virological characteristics of the SARS-CoV-2 BA.2.86 variant, finding it has higher reproduction number than EG.5.1 but lower pathogenicity and replication capacity compared to BA.2.
Yusuke Kosugi, Arnon Plianchaisuk, Olivia Putri…·Kei Sato
This study investigates the virological properties of the SARS-CoV-2 HK.3 variant, a FLip variant with substitutions S:L455F and S:F456L, to assess its growth advantage.
Keiya Uriu, Jumpei Ito, Yusuke Kosugi…·Kei Sato
This study investigates the transmissibility, infectivity, and immune resistance of the SARS-CoV-2 BA.2.86 variant, finding it to be highly immune evasive but with lower infectivity compared to other variants.